Xenon's polarizability (about 4 compared with 0.2 for He) contributes to its affinity for hydrophobic cavities in proteins, which is relevant not only for protein crystallography but also for ...

Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today ...

“We expect the next 12 to 24 months will represent a catalyst-rich period for Xenon as we continue to advance our deep pipeline of promising late- and early-stage programs across multiple ...

Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report) was the recipient of some unusual options trading activity on Wednesday. Traders purchased 4,063 put options on the stock. This represents an ...

Wedbush lowered the firm’s price target on Xenon Pharmaceuticals (XENE) to $42 from $43 and keeps an Outperform rating on the shares. Most ...

In a recent filing with the Securities and Exchange Commission, Xenon Pharmaceuticals Inc. (NASDAQ:XENE) announced significant changes to its accounting oversight. On Monday, the company’s Audit ...